Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1058 (LINC01058) is a member of the class of long intergenic non-coding RNAs (lincRNAs), which are RNA transcripts typically longer than 200 nucleotides that do not overlap with protein-coding genes[1][3][7]. LINC01058, as inferred from its designation, does not encode a protein but may serve regulatory roles at the RNA level, including modulation of chromatin architecture, regulation of gene transcription, and the stabilization of other RNAs, based on well-documented generalized functions of the lincRNA family[3][5][7]. There is no evidence in the major databases reviewed that specifically identifies LINC01058 as a therapeutic drug target, biomarker, or gene linked to specific diseases, nor are there known drugs interacting with it or established mechanisms of action targeting this RNA. The functions described herein reflect the established biology of the lincRNA class, not unique attributes of LINC01058.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1058 (LINC01058).